India approves AstraZeneca’s COVID-19 vaccine

India approves AstraZeneca’s COVID-19 vaccine

NEW DELHI (Reuters) — India has approved the COVID-19 vaccine developed by AstraZeneca and Oxford University, paving the way for a huge immunization campaign in the world’s second most populous country.

Information and Broadcasting Minister Prakash Javadekar told reporters on Saturday the vaccine had been given the green light on Friday.

It is the first COVID-19 vaccine to be approved for emergency use by India, which has the highest number of infections after the United States, and comes on the day the country is running a nationwide mock drill for vaccine delivery.

Javadekar said at least three more vaccines were waiting to be approved – local company Bharat Biotch’s COVAXIN, Zydus Cadila’s ZyCoV-D and Russia’s Sputnik-V.

“India is perhaps the only country where at least four vaccines are getting ready,” he said.